Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir salt sulfate, identified by the CAS number 188062-50-2 , is a crucial drug utilized in the management of HIV infection . Its mechanism of action involves inhibiting reverse transcription , a vital enzyme for viral copying. Patients receiving this medication must undergo genetic examination prior to commencement, due to a risk of hypersensitivity sensitivity linked to the HLA-B*57:01 allele. This side effect can range from mild skin irritation to a severe, life-threatening condition . Careful monitoring and patient counseling are therefore imperative for safe and beneficial utilization of abacavir compound.

Abarelix: Delving into Compound 183552-38-7

Abarelix, represented by compound 183552-38-7, is a artificially-produced decapeptide designed for the therapy of enlarged prostate. This drug functions as a selective gonadotropin-releasing hormone (GnRH) antagonist , effectively diminishing testosterone production. Research into the substance has focused on its ability to lessen associated conditions and potentially offer an alternative to conventional interventions. The molecular profile of 183552-38-7 is sophisticated , showcasing a particular amino acid sequence resulting in its particular mechanism of effect . Additional clinical trials are ongoing to fully assess its future safety and efficacy .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone ester is a copyrightal blocker of CYP17A1, an enzyme crucial for testosterone biosynthesis. Its structural formula is C26H30O3, and it’s widely identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing a identifier for precise identification. The medication 's properties include high affinity for CYP17A1, resulting in reduced androgen concentrations and exhibiting a white to off-white crystalline form appearance. Further analysis using analytical techniques is usually conducted to establish identity and purity .

CAS Number Spotlight: Abacavir Sulfate Form – The CAS 188062-50-2

This piece examines on a significant pharmaceutical ingredient : Abacavir Sulfate , identified by its specific Chemical Abstracts Service (CAS) designation: 188062-50-2. This medication is a key part in the therapy of the HIV infection, frequently used in along with other antiretroviral medications . Understanding this chemical number is important for scientists in the healthcare field.

Key aspects regarding Abacavir Sulfate Salt :

  • Purpose: Serves as a nucleoside reverse transcriptase blocker .
  • Utility: Primarily used in AIDS treatment .
  • Recognition : The unique code 188062-50-2 offers accurate recognition.

Analyzing Abarelix: Structural Identity (183552-38-7)

Abarelix, identified by the registration designation 183552-38-7, represents a fascinating demonstration within the realm of hormone study. Its intricate configuration is crucial to its pharmacological role. Fundamentally, this entity is a synthetic decapeptide, designed to target and antagonize gonadotropin-releasing GnRH. The structural formula reveals a sequence of units carefully ordered to facilitate a specific interaction with the GnRH site.

  • Additional research are pursued to fully determine its mechanism of effect.
  • Understanding its synthesis is vital for expanding production.
  • The exact order dictates its power.

Abiraterone Compound (154229-18-2): Functions and Chemical Profile

{Abiraterone Salt , with the CAS number 154229-18-2, is a medication primarily employed in the management of metastatic prostate malignancy , specifically those containing mutations in the PTEN pathway. It functions as an blocker of copyrightal P450c17, an enzyme responsible for androgen biosynthesis . Chemically, it’s a synthetic copyright with a complex ASCOMYCIN 11011-38-4 design , designed to effectively reduce androgen levels. Its therapeutic purpose has significantly advanced outcomes for patients with metastatic prostate malignancy.

Leave a Reply

Your email address will not be published. Required fields are marked *